The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Burden of cytokine release syndrome (CRS) and neurologic events (NE) in patients (Pts) with relapsed/refractory non-Hodgkin lymphoma (NHL) receiving lisocabtagene maraleucel (Liso-cel; JCAR017) in TRANSCEND NHL 001.
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; Novartis; Seagen; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); genentech (Inst); Juno Therapeutics (Inst); Seagen (Inst)
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics
 
Jacob Garcia
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Amgen; Celgene
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Travel, Accommodations, Expenses - Celgene
 
Christine Dehner
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
 
Andy Nguyen
Consulting or Advisory Role - Juno Therapeutics (Inst)
 
Sophie Snyder
Consulting or Advisory Role - Juno Therapeutics
 
Matthew Gitlin
Employment - BluePath Solutions
Leadership - BluePath Solutions
Consulting or Advisory Role - Juno Therapeutics
Research Funding - Juno Therapeutics
Travel, Accommodations, Expenses - Juno Therapeutics
 
Karen C. Chung
Employment - Celgene; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Amgen; Celgene